Intranasal medicinal composition containing bilastine and mometasone furoate

A technology of mometasone furoate and bilastine, which is applied in the directions of drug combinations, medical preparations containing active ingredients, non-active ingredients of polymer compounds, etc., can solve the problems of bilastine drops that are not reported in the literature. , to achieve the effect of improving medication compliance, excellent nasal sensation, and excellent stability
CN103736098AInactive Publication Date: 2014-04-23于运红

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
于运红
Publication Date
2014-04-23
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
  • Figure 3
    Figure 3
Patent Text Reader

Abstract

The invention provides an intranasal medicinal composition. The intranasal medicinal composition contains bilastine, mometasone furoate, and thaumatin serving as a bitterness and irritation alleviator.
Need to check novelty before this filing date? Find Prior Art

Description

field of invention

[0001] The present invention relates to a pharmaceutical composition for intranasal administration containing mometasone furoate and bilastine, in particular to a pharmaceutical composition for intranasal administration, which uses thaumatin to relieve bilastine The bitterness and irritation of the nose improves the nasal dripping feeling. Background of the invention

[0002] Mometasone furoate, as a steroid drug for the treatment of allergic rhinitis, is known to have an excellent effect of continuously relieving symptoms, and bilastine, as a short-acting antihistamine, is known to have an excellent ability to immediately improve symptoms. Therefore, when these two drugs are administered as a combined preparation, it is expected to exhibit an excellent effect in the long-term treatment of allergic rhinitis while improving symptoms immediately.

[0003] Bilastine is a highly selective histamine H1 receptor antagonist without sedative effect, which is used...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More